{
  "retracted": false,
  "timestamp": 1544486400000,
  "updates": [
    {
      "timestamp": 1581642629743,
      "identifier": {
        "doi": "10.1212/wnl.0000000000006636"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1212/wnl.0000000000005756"
  },
  "publisher": "Ovid Technologies (Wolters Kluwer Health)",
  "title": "Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy"
}
